FDA Import Refusal 1FX-5544940-9/20002/2 — CIPLA LTD
The FDA refused shipment 1FX-5544940-9/20002/2 from CIPLA LTD (India) on Jul 24, 2026. The refused product falls under Drugs and Biologics — NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 24, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDB84 NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75